Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00636129 · ClinicalTrials.gov registry record
Biochemical and Physiological Changes Associated With Differing Durations of Relaxation Response Training
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 30
- Enrollment target
NCT00636129: Completed study, sponsored by Massachusetts General Hospital.
NCT00636129 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00636129 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
We are looking at the effects of Stress Management and Relaxation Response training on stress hormones (like adrenalin and cortisol), immune function and physiology (heart rate, breathing rate, muscle tension).
Interventions
- BEHAVIORAL Relaxation Response + Stress Management Curriculum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-12 |
| Est. Completion | 2011-03 |
What the finished NCT00636129 record still lists
NCT00636129 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Relaxation Response + Stress Management Curriculum is the first listed.
NCT00636129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00636129 about?
NCT00636129 is a clinical study titled "Biochemical and Physiological Changes Associated With Differing Durations of Relaxation Response Training". We are looking at the effects of Stress Management and Relaxation Response training on stress hormones (like adrenalin and cortisol), immune function and physiology (heart rate, breathing rate, muscle tension).
What is the current status of trial NCT00636129?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-12. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00636129?
The interventions under investigation include: Relaxation Response + Stress Management Curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT00636129?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia